[144] Dave Inc./DE SEC Filing
Form 144 notice from the holder of DAVE common stock proposes to sell 50,000 shares through Morgan Stanley Smith Barney LLC on the NASDAQ. The filing shows the shares were acquired in a private transaction from the issuer on 08/09/2023 and were paid for in cash. The proposed sale has an aggregate market value of $11,471,000 and the issuer reports 12,084,643 shares outstanding, with an approximate sale date listed as 09/15/2025. The filer certified no undisclosed material adverse information and indicated no securities of the issuer were sold by the account in the past three months.
- Full Rule 144 disclosure provided with acquisition details, broker, proposed sale date, and outstanding shares
- Securities were paid in cash at acquisition (08/09/2023), simplifying provenance of the position
- Brokerage route documented: Morgan Stanley Smith Barney LLC named as the executing broker
- High aggregate sale value of $11,471,000 may be material to some stakeholders given its dollar size
- No trading-plan date is indicated, so the sale appears to be a proposed open-market disposition rather than a 10b5-1 plan
Insights
TL;DR: Insider plans to sell 50,000 DAVE shares (proposed value $11.47M) via a major broker; disclosure is routine but material in dollar terms.
The filing documents a proposed sale of 50,000 common shares through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $11,471,000. The shares were acquired in a private transaction and paid in cash on 08/09/2023. For investors, the key facts are the size of the position being offered and that no other sales by the account were reported in the past three months. This is a standard Rule 144 notification providing required transparency for an officer/director/affiliate or other covered person preparing to sell restricted or control securities.
TL;DR: Filing meets Rule 144 disclosure elements; signer attests no undisclosed material adverse information.
The form includes required acquisition details (private transaction, cash payment), broker information, number of shares outstanding, and an attestation regarding material disclosures. The presence of a major brokerage firm and the explicit representation about material information align with standard compliance expectations. The document does not report any sales in the prior three months, and no trading plan date is provided on the form.